Sectors

PPBT
Purple Biotech Ltd.
1.35
1 x 1.35
1 x 1.39
bid
ask
-
0.04
2.88%
09:45 AM
timesize
Ytd-79.48%
1y-95.05%
1.35
day range
1.41
1.35
52 week range
29.00
Open1.41Prev Close1.39Low1.35High1.41Mkt Cap191.92K
Vol6.59KAvg Vol308.79KEPS-20.63P/E-0.07Forward P/E-1.69
Beta0.68Short Ratio0.43Inst. Own9.33%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1850-d Avg2.37200-d Avg5.091yr Est33.00
Income Statement
Operating Expenses2.25M
Research and Development Expense1.23M
Selling, General and Administrative Expense1.02M
Operating Income-2.25M
Interest Expense31.00K
Net Income86.00K
Net Income Common Stock86.00K
Net Income Common Stock (USD)86.00K
Consolidated Income-89.00K
Net Income to Non-Controlling Interests6.00K
Earning Before Interest & Taxes (EBIT)117.00K
Earning Before Interest & Taxes (USD)117.00K
Weighted Average Shares1.86B
Balance Sheet
Cash and Equivalents5.57M
Cash and Equivalents (USD)5.57M
Investments859.00K
Investments Current859.00K
Current Assets6.78M
Property, Plant & Equipment Net278.00K
Total Assets14.42M
Debt Current184.00K
Total Debt184.00K
Current Liabilities4.59M
Total Liabilities4.75M
Accumulated Retained Earnings (Deficit)-171.17M
Shareholders Equity9.72M
Shareholders Equity (USD)9.72M
Assets Non-Current7.64M
Total Debt (USD)184.00K
Goodwill and Intangible Assets7.36M
Liabilities Non-Current160.00K
Trade and Non-Trade Payables2.51M
Cash Flow
Depreciation, Amortization & Accretion65.00K
Net Cash Flow from Financing-64.00K
Net Cash Flow / Change in Cash & Cash Equivalents-3.14M
Issuance (Repayment) of Debt Securities -59.00K
Net Cash Flow from Investing45.00K
Net Cash Flow - Investment Acquisitions and Disposals2.00K
Net Cash Flow from Operations-3.12M
Share Based Compensation93.00K